실시간
CellB cell deficiency limits exercise capacity by remodeling liver glutamate metabolismCellA phytoscreen identifies a garlic compound as a deterrent of mating and egg laying in <em>Drosophila</em> and mosquitoesCellp53 safeguards chemical reprogramming of human somatic cells toward pluripotencyCell2'3'-cGAMP-induced membrane shearing promotes broad antiphage immunityCellGut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockadeFierceBiotechAACR: Endeavoring to go global, Zai Lab offers reality check on China’s biotech ascentNVIDIAGoogle developing inference AI chips to rival Nvidia - qz.comCorningSpring book sale returns to benefit Southeast Steuben County Library - WETMBioPharma DiveRFK Jr. defends HHS tenure, 12% proposed budget cutInsilico MedicineInsilico Medicine Highlights AI Benchmarking Platform for Drug Discovery - TipRanksBDBD Wong to Star in Solo Performance of The Glass Menagerie for Philadelphia Theatre Company - TheaterManiaIlluminaTsinghua University brings hands-on multiomics training to young scientists - Illumina
Endpoints News 2026년 2월 23일

Novo Nordisk’s CagriSema beaten by Lilly’s Zepbound in head-to-head obesity trial

Novo Nordisk’s CagriSema beaten by Lilly’s Zepbound in head-to-head obesity trial

원문
본문을 이용할 수 없습니다. 원본 출처를 확인하세요.